---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-23-017427"
form_type: "8-K"
ticker: "BVS"
cik: "0001665988"
company_name: "Bioventus Inc."
filed_at: "2023-05-11T23:59:59+00:00"
generated_at: "2026-06-15T04:15:37.548343+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Bioventus delays Q1 10-Q filing; prelim revenue ~$119M, Adj. EBITDA ~$17M

## Summary
- Filing delayed due to complexity in tax structure and noncontrolling equity interest calculation.
- Preliminary Q1 revenue ~$119M; Adjusted EBITDA ~$17M; no impact on revenue or EBITDA from the calculation.
- Company expects to file Form 10-Q by May 16, 2023, and remain in compliance with all financial covenants.
- Earnings call rescheduled to May 16, 2023 at 8:30 a.m. ET.

## SEC filing metadata
- accession: 0001628280-23-017427
- form_type: 8-K
- ticker: BVS
- cik: 0001665988
- company_name: Bioventus Inc.
- filed_at: 2023-05-11T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1665988/000162828023017427/0001628280-23-017427-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1665988/000162828023017427/bvs-20230511.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-23-017427
- JSON: https://secwatch.observer/filing/0001628280-23-017427.json
- Plain text: https://secwatch.observer/filing/0001628280-23-017427.txt

## Key facts
- Earnings Releases
  Bioventus Inc. reported the quarter ended April 1, 2023 results: revenue approximately $119 million.
  - Period: the quarter ended April 1, 2023
  - Revenue: approximately $119 million
  - Result: preliminary results
  source text: At this time, the Company expects to report revenue for the quarter ended April 1, 2023, of approximately $119 million and Adjusted EBITDA of approximately $17 million.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1665988/000162828023017427/0001628280-23-017427-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.